Intelligent Ultrasound Group PLC Formation of Nomination Committee (0924Z)
September 16 2020 - 1:00AM
UK Regulatory
TIDMMED
RNS Number : 0924Z
Intelligent Ultrasound Group PLC
16 September 2020
Intelligent Ultrasound Group plc
("Intelligent Ultrasound" or the "Company")
Formation of Nomination Committee
Intelligent Ultrasound (AIM: MED), the artificial intelligence
(AI) based ultrasound software and simulation company, announces
the formation of a Nomination Committee of The Board of
Directors.
While to date, Intelligent Ultrasound has used the whole board
to consider matters of nomination, given the Company's current
maturity and the nature of its current board composition, the
Company is establishing a more focused Nomination Committee to lead
its process for appointments and oversee the development of a
diverse pipeline for succession.
As set out in its chosen governance code, the QCA's Corporate
Governance Code (the "Code"), the Nomination Committee will seek
"to identify the skills, experience, personal qualities and
capabilities required for the next stage in the company's
development, linking the company's strategy to future changes on
the board"
As required by the Code, details of the Terms of Reference for
the Intelligent Ultrasound Nomination Committee can be found on the
Company's website
www.intelligentultrasoundgroup.com/directors-and-committees
Riccardo Pigliucci, Non-Executive Chairman, said:
"Intelligent Ultrasound is transitioning from the typical
Founders and Venture driven company to a more mature public entity
and as such it is time to reconfigure our Board to comply with both
the independence and the seniority requirement of today's public
companies. I look forward to updating investors over time on new
independent non-executive director appointments and Board changes
as they become effective."
For further information, please contact:
Intelligent Ultrasound Group plc www. intelligentultrasound.com
Stuart Gall, CEO Tel: +44 (0)29 2075 6534
Helen Jones, Group Finance Director
Cenkos Securities - Nominated Advisor Tel: +44 (0)20 7397 8900
and Broker
Giles Balleny / Cameron MacRitchie (Corporate
Finance)
Michael Johnson / Julian Morse (Sales)
Walbrook PR Tel: +44 (0)20 7933 8780 or intelligentultrasound@walbrookpr.com
Anna Dunphy / Paul McManus Mob: +44 (0)7876 741 001 / Mob: +44 (0)7980 541
893
About Intelligent Ultrasound Group
Intelligent Ultrasound (AIM: MED) develops artificial
intelligence-based clinical image analysis software tools for the
diagnostic medical ultrasound market and hi-fidelity virtual
reality simulators for the ultrasound training market.
Based in Cardiff in the UK, Atlanta in the US and with
representation in Beijing in Asia, the Group operates two
divisions:
Clinical AI Division
Focusses on developing deep learning-based algorithms to make
ultrasound machines smarter and more accessible. Products in
development include ScanNav which uses machine-learning based
algorithms to automatically identify and grade ultrasound images to
provide scan assessment and audit of protocol-based ultrasound
scanning; and AnatomyGuide, which aims to simplify
ultrasound-guided needling by providing the user with real-time
AI-based needle guidance software for a range of medical
procedures.
Simulation Division
Focusses on hi-fidelity ultrasound education and training
through simulation. Its three main products are the ScanTrainer
OBGYN training simulator, the HeartWorks echocardiography training
simulator and the BodyWorks Eve Point of Care and Emergency
Medicine training simulator. To date over 900 simulators have been
sold to almost 500 medical institutions around the world.
www.intelligentultrasound.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCSFSFWIESSEFU
(END) Dow Jones Newswires
September 16, 2020 02:00 ET (06:00 GMT)
Intelligent Ultrasound (LSE:IUG)
Historical Stock Chart
From Apr 2024 to May 2024
Intelligent Ultrasound (LSE:IUG)
Historical Stock Chart
From May 2023 to May 2024